A Massachusetts-based pharmaceutical company is recalling medication used to treat Attention Deficit Attention Disorder and narcolepsy due to the possibility the bottles contain the wrong medication.

Azurity Pharmaceuticals Inc. recalled a lot of Zenzedi CII 30 mg pills after a pharmacist in Nebraska opened a bottle and found it contained carbinoxamine maleate, an antihistamine, the Food and Drug Administration announced.

People who take carbinoxamine are at risk of not having their ADHD or narcolepsy symptoms treated but also of drowsiness, central nervous system depression, increased eye pressure and more from the antihistamine.

Azurity has not received any reports of serious adverse events related to the recall.

Zenzedi is a light yellow hexagonal tablet with “30″ on one side and “MIA”  on the other. Carbinoxamine is a white round tablet with “GL” on one side and “211 on the other.”

You can go here to a list of lot numbers.

Azurity is working with wholesalers and retailers to arrange for replacements of the recalled products. Customers who have the product are urged not to use them and return them to their place of purchase. You can get more information on the recall at 1-877-804-2069.